Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ChemBioID - An integrated chemical biology workflow for the investigation of proximity-induced pharmacology

ABSTRACT: Modulation of protein-protein interactions with small molecules represents an emerging area of interest in drug discovery. Here we probe the effects of catalytic inhibition of CAMKK2 on the proximity of PRKAA1. The experiment was supervised by Sabrina Keller and Viviane Reber. This project is part of the IMI EUbOPEN project.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Early Embryonic Cell

SUBMITTER: Stefanie Loosli

LAB HEAD: Matthias Gstaiger

PROVIDER: PXD058471 | Pride | 2025-04-30

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	190417_Human_sp_only_iRT.fasta	Fasta
	20240319_070728_sloosl_BioID1_EGFP_DIA.sne	Other
	20240320_155309_sloosl_BioID1_5562_DIA.sne	Other
	202403_sloosl_BioID1_EGFP_DIA_Report.tsv	Tabular
	202403_sloosl_BioID1_PRKAA1_DIA_Report.tsv	Tabular

Items per page:

1 - 5 of 39

Similar Datasets

ChemBioID - An integrated chemical biology workflow for the investigation of proximity-induced pharmacology

Project description:Modulation of protein-protein interactions with small molecules represents an emerging area of interest in drug discovery. Here we probe the effects of catalytic inhibition on the proximity of CAMKK2. The experiment was supervised by Sabrina Keller and Viviane Reber. This project is part of the IMI EUbOPEN project.

2025-04-30 | PXD058412 | Pride

ChemBioID - An integrated chemical biology workflow for the investigation of proximity-induced pharmacology

2025-04-30 | PXD058418 | Pride

ChemBioID - An integrated chemical biology workflow for the investigation of proximity-induced pharmacology of BIRC2 by the compounds AZD5582 and GDC0152

Project description:Modulation of protein-protein interactions with small molecules represents an emerging area of interest in drug discovery, enabling new therapeutic paradigms unprecedented with other drug classes such as catalytic enzyme inhibitors. Immunomodulatory drugs are a prime example for proximity-induced pharmacology where in the case of multiple myeloma, degradation of oncogenic transcription factors is achieved via recruitment of an E3 ligase complex. Here, we present a streamlined workflow for profiling small molecule degraders, integrating proteomics-based techniques such as proximity labelling, in-cell interaction validation assays, ubiquitination analysis and protein degradation monitoring. Application of this combined approach to a set of degraders enabled us to identify known and novel IMiD-dependent CRBN binders, thereby revealing the extended recruitment capacity of these compounds and raising important questions about potential degrader pharmacology beyond the dogma of recruitment, ubiquitination and degradation. This project is part of the IMI EUbOPEN project.

2025-04-30 | PXD056535 | Pride

ChemBioID - An integrated chemical biology workflow for the investigation of proximity-induced pharmacology of BIRC3 by the compounds AZD5582 and GDC0152

2025-04-30 | PXD056541 | Pride

ChemBioID - An integrated chemical biology workflow for the investigation of proximity-induced pharmacology

2025-04-30 | PXD055545 | Pride

ChemBioID - An integrated chemical biology workflow for the investigation of proximity-induced pharmacology of CSNK by the compound lenalidomide

2025-04-30 | PXD056551 | Pride

ChemBioID - An integrated chemical biology workflow for the investigation of proximity-induced pharmacology by the compound NVS-BPTF-1-B

2025-04-30 | PXD056164 | Pride

ChemBioID - An integrated chemical biology workflow for the investigation of proximity-induced pharmacology by the compound NVS-BPTF-A-2

2025-04-30 | PXD056314 | Pride

ChemBioID - An integrated chemical biology workflow for the investigation of proximity-induced pharmacology by the compound ASM-01-130